Education
About Us
Working with TipRanks
Follow Us
NEXTAGE Therapeutics Ltd. (IL:NXTG)
:NXTG
NXTG Stock Chart & Stats
Day’s Range― - ―
52-Week Range53.00 - 119.00
Previous CloseN/A
Volume8.69K
Average Volume (3M)40.66K
Market Cap
77.08M
Enterprise ValueN/A
Total Cash (Recent Filing)404.00K
Total Debt (Recent Filing)378.00K
Price to Earnings (P/E)―
Beta0.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding80,294,680
10 Day Avg. Volume30,708
30 Day Avg. Volume40,660
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NXTG FAQ
What was NEXTAGE Therapeutics Ltd.’s price range in the past 12 months?
NEXTAGE Therapeutics Ltd. lowest stock price was 53.00 and its highest was 119.00 in the past 12 months.
What is NEXTAGE Therapeutics Ltd.’s market cap?
NEXTAGE Therapeutics Ltd.’s market cap is 77.08M.
When is NEXTAGE Therapeutics Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NEXTAGE Therapeutics Ltd.’s earnings last quarter?
NEXTAGE Therapeutics Ltd. released its earnings results on Aug 29, 2021. The company reported -11 earnings per share for the quarter, missing the consensus estimate of N/A by -11.
Is NEXTAGE Therapeutics Ltd. overvalued?
According to Wall Street analysts NEXTAGE Therapeutics Ltd.’s price is currently Overvalued.
Does NEXTAGE Therapeutics Ltd. pay dividends?
NEXTAGE Therapeutics Ltd. does not currently pay dividends.
What is NEXTAGE Therapeutics Ltd.’s EPS estimate?
NEXTAGE Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NEXTAGE Therapeutics Ltd. have?
NEXTAGE Therapeutics Ltd. has 80,294,680 shares outstanding.
What happened to NEXTAGE Therapeutics Ltd.’s price movement after its last earnings report?
NEXTAGE Therapeutics Ltd. reported an EPS of -11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of NEXTAGE Therapeutics Ltd.?
Currently, no hedge funds are holding shares in IL:NXTG
Company Description
NEXTAGE Therapeutics Ltd.
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.